97284 ⎘
Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL Framework region [FR]
Construction of diverse synthetic peptide and polypeptide libraries
#1802Antibodies to IL-6 and their uses
#1803Common Light Chain Mouse
#1804Antibiotic comprising an antibody mimetic, its preparation methods and uses thereof
#1805Detection of amyloid deposits using anti-amyloid antibodies
#1806ANTI-CD38 HUMAN ANTIBODIES AND USES THEREOF
#1807Anti-CD19 antibodies
#1808Meditopes and related meditope-monoclonal antibody delivery systems, synthesis and therapeutic uses thereof
#1809High affinity antibodies that neutralize enterotoxin B
#1810Binding members for interleukin-4 receptor alpha (IL-4Ra) - 173
#1811Immuno-conjugates and methods for producing them
#1812ANIMAL MODELS AND THERAPEUTIC MOLECULES
#1813Anti-IL13 antibodies and uses thereof
#1814Immuno-conjugates and methods for producing them
#1815Gram-positive bacteria specific binding compounds
#1816Anti-IL13 antibodies and uses thereof
#1817Soluble “heavy-chain only” antibodies
#1818Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
#1819Anti-CD79B antibodies and immunoconjugates and methods of use
#1820Methods for identification of sites for IgG conjugation
#1821Variant immunoglobulins with improved manufacturability
#1822Ig-pCONSENSUS GENE VACCINATION PROTECTS FROM ANTIBODY-DEPENDENT IMMUNE PATHOLOGY IN AUTOIMMUNE DISEASE
#1823POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS & ANTAGONISTS
#1824Ligands that bind TGF-β receptor RII
#1825Design and construction of diverse synthetic peptide and polypeptide libraries
#1826Collection and methods for its use
#1827MUC1 antibodies
#1828C3b antibodies and methods for the prevention and treatment of complement-associated disorders
#1829NEUTRALIZING MOLECULES TO INFLUENZA VIRUSES
#1830Monovalent, bivalent and trivalent anti human respiratory syncytial virus (HRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections
#1831POLYNUCLEOTIDE AND POLYPEPTIDE SEQUENCES INVOLVED IN CANCER
#1832Fusion antibodies for HIV therapy
#1833Human monoclonal antibodies against protective antigen
#1834Human antibodies to human TNF-like ligand 1A (TL1A)
#1835Antibodies for epidermal growth factor receptor 3 (HER3)
#1836Anti-TAT226 antibodies and immunoconjugates
#1837Humanized anti-IL-18 antibodies
#1838Humanized anti-human tumor necrosis factor alpha monoclonal antibody and sequence thereof
#1839Neutralizing molecules to viral antigens
#1840ANTI-VEGF-D ANTIBODIES
#1841ANTIBODY COMPOSITIONS AND METHODS OF USE
#1842Collection and methods for its use
#1843METHOD FOR AN IN VITRO MOLECULAR EVOLUTION OF ANTIBODY FUNCTION
#1844Amino acid sequences directed against the Angiopoietin/Tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesis
#1845HUMANIZED ANTIBODIES AGAINST WEST NILE VIRUS AND THERAPEUTIC AND PROPHYLACTIC USES THEREOF
#1846Anti-influenza M2e antibody
#1847Stable and soluble antibodies inhibiting TNFα
#1848FGFR1C ANTIBODY COMBINATIONS
#1849Anti-IL-6 antibodies, compositions, methods and uses
#1850Engineered anti-IL-13 antibodies, compositions, methods and uses
#1851Anti-amyloid antibodies
#1852Compositions and methods of use for antibodies of dickkopf-1
#1853Antibodies to the PcrV antigen of
#1854Stable and soluble antibodies inhibiting VEGF
#1855Alpha5-beta1 antibodies and their uses
#1856Methods of using anti-CGRP antagonist antibodies
#1857IMMUNOGLOBULIN VARIANTS WITH ALTERED BINDING TO PROTEIN A
#1858VARIANT DOMAIN ANTIBODIES
#1859Anti-rhesus D monoclonal antibody
#1860AGENTS FOR HCV TREATMENT
#1861PULMONARY ADMINISTRATION OF IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS AND CONSTRUCTS THEREOF
#1862Isolated antibodies which bind to CXC chemokine receptor 4
#1863Anti-αβantibodies and uses thereof
#1864AMINO ACID SEQUENCES DIRECTED AGAINST INTEGRINS AND USES THEREOF
#1865Antibodies to human GDF8
#1866Compositions and methods for diagnosing and treating an inflammation
#1867Compositions and methods for diagnosing and treating an inflammation
#1868TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASE
#1869Antibodies that bind colony stimulating factor 1 receptor (CSF1R)
#1870Solubility optimization of immunobinders
#1871ANTI-INTERFERON-ALPHA ANTIBODIES
#1872Anti-CD38 human antibodies and uses thereof
#1873Anti-IL-12/IL-23 antibodies
#1874AMINO ACID SEQUENCES THAT MODULATE THE INTERACTION BETWEEN CELLS OF THE IMMUNE SYSTEM
#1875IMMUNOGLOBULINS DEVOID OF LIGHT CHAINS
#1876POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS & ANTAGONISTS
#1877Monoclonal antibodies against HER2 antigens, and uses therefor
#1878Antibodies against IL-25
#1879Antigens associated with endometriosis, psoriatic arthritis and psoriasis
#1880TNF-α binding proteins
#1881Anti-IL-6 Receptor Antibody
#1882Universal antibody libraries
#1883METHODS OF GENERATING VARIANT PROTEINS WITH INCREASED HOST STRING CONTENT AND COMPOSITIONS THEREOF
#1884Hybrid antibodies
#1885Anti-NR10 antibody and use thereof
#1886TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS
#1887Chimeric, humanized, or human antibody 2A4
#1888Monoclonal antibodies directed to CD20
#1889Nucleic acids encoding monoclonal antibodies to programmed death ligand 1 (PD-L1)
#1890Antibodies to lymphotoxin-α
#1891IL-23 ANTIBODIES
#1892Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases
#1893Anti-interferon-α antibodies
#1894Methods of using insulin-like growth factor antibodies to treat tumors
#1895IDENTIFICATION OF NOVEL IgE EPITOPES
#1896Common light chain mouse
#1897IMMUNOGLOBULIN CONSTRUCTS
#1898Compositions and methods for diagnosing and treating an inflammation
#1899Anti-hepcidin-25 selective antibodies and uses thereof
#1900SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST TUMOR NECROSIS FACTOR-ALPHA AND USES THEREFOR
#1901Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases
#1902HUMANIZED ANTI-CD22 ANTIBODIES AND THEIR USE IN TREATMENT OF ONCOLOGY, TRANSPLANTATION AND AUTOIMMUNE DISEASE
#1903Anti-HER2 antibodies and their uses
#1904IL-17 receptor A antigen binding proteins
#1905Biological products
#1906Humanized antibodies
#1907Antibodies against human CSF-1R and uses thereof
#1908Methods of inhibiting inflammation with antagonists to IL-17A, IL-17F, and IL-23P19
#1909Human antibodies to human angiopoietin-like protein 4
#1910Method for treating glioblastoma using antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK
#1911Stable and soluble antibodies inhibiting TNFα
#1912Engineered Anti-IL-23R Antibodies
#1913Humanized antibodies that sequester amyloid beta peptide
#1914METHODS OF PREVENTING AND TREATING RSV INFECTIONS AND RELATED CONDITIONS
#1915Antibodies to lymphotoxin-α
#1916Humanized antibodies that recognize beta amyloid peptide
#1917Compositions and methods for the diagnosis and treatment of tumor
#1918SUPER HUMANIZED ANTIBODIES
#1919Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment
#1920Anti-CD79B antibodies and immunoconjugates and methods of use
#1921Methods of treating retinal nerve fiber layer degeneration with monoclonal antibodies against a retinal guidance molecule (RGM) protein
#1922Anti-alpha2 integrin antibodies and their uses
#1923ANTI-NR10 ANTIBODY AND USE THEREOF
#1924Generation and affinity maturation of antibody library in silico
#1925TREATMENT WITH ANTI-VEGF ANTIBODIES
#1926IMMUNOGLOBULIN SINGLE VARIABLE DOMAIN DIRECTED AGAINST HUMAN CXCR4 AND OTHER CELL ASSOCIATED PROTEINS AND METHODS TO GENERATE THEM
#1927Monoclonal antibody specific to anthrax toxin
#1928Humanization of rabbit antibodies using a universal antibody framework
#1929Monoclonal antibodies to progastrin and their uses
#1930Therapeutic DLL4 binding proteins
#1931Heparin-binding epidermal growth factor-like growth factor binding proteins
#1932Anti-HIV domain antibodies and method of making and using same
#1933Treatment of chronic prostatitis
#1934Anti-TrkB antibodies
#1935Human Anti-NGF Neutralizing Antibodies as Selective NGF Pathway Inhibitors
#1936Humanized antibodies to interferon alpha receptor-1 (IFNAR-1)
#1937POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS AND ANTAGONISTSMETHODS FOR
#1938ANTIBODIES THAT BIND INTERLEUKIN-4 RECEPTOR
#1939Methods of treating conditions using anti-IL-6 antibodies
#1940Synthetic scFv analogue to the 6313/G2 (anti angiotensin II type 1 receptor) monoclonal antibody variable regions
#1941ANTI-VEGF ANTIBODIES
#1942Methods of using IL-17 receptor a antibodies
#1943Humanized anti-FGF19 antagonists and methods using same
#1944Compositions and methods relating to anti-IGF-1 receptor antibodies
#1945Antigen binding proteins
#1946CA6 antigen-specific cytotoxic conjugate and methods of using the same
#1947Immunoglobulin Variants Outside the Fc Region
#1948High affinity, anti-human IgE antibodies
#1949Class I anti-CEA antibodies and uses thereof
#1950Amino acid sequences directed against HER2 and polypeptides comprising the same for the treatment of cancers and/or tumors
#1951IL-23 antagonists
#1952Transgenic animal for production of antibodies having minimal CDRS
#1953AMINO ACID SEQUENCES DIRECTED AGAINST HETERODIMERIC CYTOKINES AND/OR THEIR RECEPTORS AND POLYPEPTIDES COMPRISING THE SAME
#1954ANTI-VEGF ANTIBODIES
#1955METHOD OF INHIBITION OF LEUKEMIC STEM CELLS
#1956Anti-CD19 antibodies
#1957Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors
#1958Treatment and prophylaxis of amyloidosis
#1959ANTI-ErbB2 ANTIBODIES
#1960METHOD FOR OBTAINING POLYPEPTIDE CONSTRUCTS COMPRISING TWO OR MORE SINGLE DOMAIN ANTIBODIES
#1961BINDING POLYPEPTIDES WITH OPTIMIZED SCAFFOLDS
#1962SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST TUMOR NECROSIS FACTOR-ALPHA AND USES THEREFOR
#1963Anti-CD40 antibodies and methods of inhibiting proliferation of CD40 expressing cells
#1964Humanized anti-CXCR5 antibodies, derivatives thereof and their use
#1965Hybrid antibodies
#1966Human anti-mesothelin monoclonal antibodies
#1967GRAM-POSITIVE BACTERIA SPECIFIC BINDING COMPOUNDS
#1968Anti-IL 13 antibodies and uses thereof
#1969Polynucleotides encoding IL-17 receptor A antigen binding proteins
#1970Antibodies to TGFβ
#1971Compositions and methods of tolerizing a primate to an antigen
#1972Amino acid sequences directed against RANK-L and polypeptides comprising the same for the treatment of bone diseases and disorders
#1973Antibodies directed to αVβ6 and uses thereof
#1974Alpha 5-beta 1 antibodies and their uses
#1975PHAGE-DISPLAYING SINGLE-CHAIN ANTIBODY CAPABLE OF RECOGNIZING NON-REDUCED MANNOSE RESIDUE
#1976MEANS AND METHODS FOR ENHANCING DIFFERENTIATION OF HAEMATOPOIETIC PROGENITOR CELLS
#1977Humanised antibodies with anti-tumour activity
#1978Ganglioside associated recombinant antibodies and the use thereof in the treatment of tumors
#1979Humanized platelet activating factor antibody design using anti-lipid antibody templates
#1980Anti-IL-17 receptor A neutralizing antibodies
#1981ANTIBODY HAVING INHIBITORY ACTIVITY ON INFECTION WITH HEPATITIS C VIRUS (HCV) AND USE THEREOF
#1982Crystal structures and methods using same
#1983Polypeptides, antibody variable domains and antagonists
#1984Antibodies specific for DKK-1 and their uses
#1985Method for separating viable cells, apoptotic and dead cells
#1986Humanized anti-EGFL7 antibodies and methods using same
#1987Anti-CD38 human antibodies and uses thereof
#1988Monoclonal Antibodies Against PCBP-1 Antigens, and Uses Therefor
#1989Polypeptides, antibody variable domains and antagonists
#1990Treatment of cancer with novel anti-IL13 monoclonal antibodies
#1991Polypeptides, antibody variable domains and antagonists methods for
#1992POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS AND ANTAGONISTS
#1993Engineered anti-alpha V-integrin hybrid antibodies
#1994METHODS FOR SELECTING PROTEASE RESISTANT POLYPEPTIDES
#1995Anti-FGFR3 antibodies and methods using same
#1996POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS AND ANTAGONISTS
#1997High potency recombinant antibodies and method for producing them
#1998Ligand
#1999TARGETED BINDING AGENTS DIRECTED TO HEPARANASE AND USES THEREOF 463
#2000Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
#2001TREATMENT WITH ANTI-VEGF ANTIBODIES
#2002Anti-CD79B antibodies and immunoconjugates and methods of use
#2003Anti-influenza M2e antibody
#2004Nucleic acids encoding antibodies that bind interleukin-4 receptor
#2005Anti-PD-L1 antibodies, compositions and articles of manufacture
#2006FUNCTIONAL HUMANIZATION OF COMPLEMENTARITY DETERMINING REGIONS (CDRS)
#2007Engineered scFv against bovine herpes virus type I
#2008Method of inhibition of vascular development using an antibody
#2009IL-12/p40 binding proteins
#2010Methods of Generating Variant Proteins with Increased Host String Content
#2011Antibodies against interleukin-1 β
#2012Immunoglobulins directed to bacterial, viral and endogenous polypeptides
#2013Method for generation of immunoglobulin sequences
#2014HUMANIZED ANTI-5T4 ANTIBODIES AND ANTI-5T4/CALICHEAMICIN CONJUGATES
#2015Methods for producing active scFv antibodies and libraries therefor
#2016Engineered anti-TSLP antibody
#2017Increasing The Production Of Recombinant Antibodies In Mammalian Cells By Site-Directed Mutagenesis
#2018Sequence based engineering and optimization of single chain antibodies
#2019Engineered rabbit antibody variable domains and uses thereof
#2020Treatment of inflammation using BST2 inhibitor
#2021Serum albumin binding proteins with long half-lives
#2022Anti-Notch3 agonist antibodies and their use in the treatment of Notch3-related diseases
#2023Engineered anti-IL-13 antibodies, compositions, methods and uses
#2024Humanized antibodies to interferon alpha receptor-1 (IFNAR-1)
#2025Amino acid sequences directed against RANK-L and polypeptides comprising the same for the treatment of bone diseases and disorders
#2026Antibodies and methods for making and using them
#2027METHODS OF PREVENTING AND TREATING RSV INFECTIONS AND RELATED CONDITIONS
#2028Antibodies to CXCL13
#2029Methods of inhibiting alpha-4-dependent interactions with VCAM-1 with anti-VLA-4 antibodies
#2030Anti-Notch2 NRR antibodies
#2031IP-10 antibodies and their uses
#2032Hybrid antibodies
#2033Anti-CD19 antibodies
#2034Monoclonal antibodies
#2035Rationally designed, synthetic antibody libraries and uses therefor
#2036Fully human monoclonal antibodies to IL-13
#2037IL-12/p40 binding proteins
#2038Prevention of aggregation of immunoglobulin light or heavy chains
#2039Fusion Proteins That Contain Natural Junctions
#2040NEUTRALIZING ANTIBODIES TO INFLUENZA VIRUSES
#2041TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASE
#2042Antibodies to receptor of advanced glycation end products (RAGE) and uses thereof
#2043IL-17 RECEPTOR A ANTIGEN BINDING PROTEINS
#2044Polypeptides that modulate the interaction between cells of the immune system
#2045Antibodies against the RGM A protein and uses thereof
#2046Biological products
#2047HUMANIZED ANTI-5T4 ANTIBODIES AND ANTI-5T4/CALICHEAMICIN CONJUGATES
#2048Cripto binding molecules
#2049Human equivalent monoclonal antibodies engineered from nonhuman variable regions
#2050Humanized antibodies against west nile virus and therapeutic and prophylactic uses thereof
#2051HIGHLY DIVERSIFIED ANTIBODY LIBRARIES
#2052Antibodies to IL-6 and their uses
#2053Treatment Of Tumors Expressing Mutant EGF Receptors
#2054Nucleic acid molecules encoding minimally immunogenic variants of SDR-grafted humanized antibody CC49
#2055Metalloproteinase-12 specific monoclonal antibody
#2056DP-78-Like Nanobodies
#2057Antibodies to lymphotoxin-alpha
#2058Compositions and methods relating to anti IGF-1 receptor antibodies
#2059Antibodies and methods for making and using them
#2060ANTI-CD19 ANTIBODIES AND USES IN ONCOLOGY
#2061Antibodies and immunoconjugates and uses therefor
#2062Humanized anti-factor D antibodies and uses thereof
#2063Methods of modifying antibodies for purification of bispecific antibodies
#2064Stable and soluble antibodies inhibiting TNFα
#2065Ligand
#2066ANTI-NOTCH1 NRR ANTIBODIES AND METHODS USING SAME
#2067TREATMENT WITH ANTI-VEGF ANTIBODIES
#2068Anti-IL-6 antibody nucleic acid molecules and methods
#2069Humanized antibodies that sequester amyloid beta peptide
#2070Anti-activin A antibodies and uses thereof
#2071Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
#2072Humanized Antibodies Which Bind To AB (1-42) Globulomer And Uses Thereof
#2073Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
#2074B-CELL REDUCTION USING CD37-SPECIFIC AND CD20-SPECIFIC BINDING MOLECULES
#2075Anti-IL13 antibodies and uses thereof
#2076Negative Mimic Antibody For Use as a Blocking Reagent In BNP Immunoassays
#2077Binding members for interleukin-4 receptor alpha (IL-4Rα)-173
#2078Chimeric, humanized, or human antibody 2A4
#2079Cancer treatment using humanized antibodies that bind to EphB4
#2080Method and compositions for immunization with the V antigen
#2081Prevention and treatment of amyloidogenic disease
#2082Treatment with anti-VEGF Antibodies
#2083Humanized anti-CCR2 antibodies and methods of use therefor
#2084Antibodies to the PcrV antigen of
#2085Chimeric, human and humanized anti-granulocyte antibodies and methods of use
#2086Rationally designed, synthetic antibody libraries and uses therefor
#2087Humanized anti-ghrelin antibodies
#2088Compositions and methods of use for antibodies of c-Met
#2089Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors
#2090Immunoglobulin variants and uses thereof
#2091Human C-FMS antigen binding proteins
#2092POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS & ANTAGONISTS
#2093Antibody Compositions and Methods
#2094Methods for Producing Active scFv Antibodies and Libraries Therefor
#2095Preventive/Remedy for Cancer
#2096Anti-CD26 antibodies and methods of use thereof
#2097Combination therapies employing GITR binding molecules
#2098Methods for humanizing antibodies and humanized antibodies made thereby
#2099IMMUNOGLOBULINS
#2100Methods for use in human-adapting monoclonal antibodies